Therapeutic potential of mesenchymal stem cell-derived microvesicles

Area of Science:

• Regenerative Medicine
• Cell Biology
• Nephrology

Background:

• Mesenchymal stem cells (MSCs) show promise in reversing kidney injury via paracrine mechanisms.
• Microvesicles (MVs) released by MSCs mediate this paracrine action through horizontal transfer of biomolecules.
• MVs are crucial for intercellular communication, acting as vehicles for information exchange.

Purpose of the Study:

• To review the potential of MSC-derived MVs in regenerative medicine.
• To explore MVs as an alternative to MSC-based therapy for tissue repair.
• To discuss the role of MVs in bidirectional cell communication and tissue self-repair.

Main Methods:

• Literature review of studies on MSCs, MVs, and kidney injury.
• Analysis of MV composition (mRNA, microRNA, proteins) and function.
• Evaluation of MV therapeutic potential in experimental models.

Main Results:

• MSC-derived MVs can transfer mRNA, microRNA, and proteins, influencing recipient cell phenotypes.
• MVs facilitate bidirectional communication, potentially reprogramming stem cells or repairing injured cells.
• Administered MVs mimic MSC therapeutic effects by inhibiting apoptosis and promoting proliferation.

Conclusions:

• MSC-derived MVs hold significant potential as cell-free therapeutic agents in regenerative medicine.
• MVs offer a promising alternative to cell-based therapies for treating acute and chronic kidney injury.
• Further research into MV-based strategies could advance tissue repair and self-healing mechanisms.